News

Hylomorph secures CHF 5.2 million series-B round

The clinical-stage startup aims to minimise post-surgical complications in medical implants. Proceeds from its CHF 5.2 series B investment CHF 0.9 Million non-dilutive funding will support the company in obtaining the FDA and CE mark approval for its product portfolio, beginning with the Hylomate.

weiterlesen

CareerFairy secures CHF 1.7 million seed capital

ETH spinoff CareerFairy AG has completed its seed investment round led by the venture arm of Swiss Post together with Zurich-based VC BackBone Ventures and other prominent business angels. The funds will help accelerate the digitalisation of corporate events at universities and open up even more markets internationally.

weiterlesen